Teva Skirts $235M Infringement Verdict In Coreg Patent Row
A Delaware federal judge on Wednesday released Teva Pharmaceutical Industries Ltd. from a $235 million verdict over its generic version of GlaxoSmithKline LLC's heart medication Coreg, finding Teva did not infringe...To view the full article, register now.
Already a subscriber? Click here to view full article